Prakt. lékáren. 2022; 18(4): 219-223 | DOI: 10.36290/lek.2022.046

The use of methadone as a co-analgetic in the treatment of pain - a case report from clinical practice

Anna Králová1, 2, Zuzana Křemenová2, 3
1 Oddělení klinické farmacie Fakultní nemocnice Královské Vinohrady, Praha
2 Paliativní a podpůrný tým Fakultní nemocnice Královské Vinohrady, Praha
3 Interní klinika Fakultní nemocnice Královské Vinohrady, Praha

Methadone is now available in the Czech Republic for treatment of chronic pain. It is a medicinal substance with unique pharmacological properties used in the treatment of complicated painful conditions. Non-standard application of methadone as a co-analgesic, principles of non-linear rotation from another opioid, and moreover, management of specific adverse effects of methadone are described in the palliative medicine case study.

Keywords: methadone, treatment of pain, pharmacokinetics, adverse effects.

Accepted: December 1, 2022; Published: December 15, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králová A, Křemenová Z. The use of methadone as a co-analgetic in the treatment of pain - a case report from clinical practice. Praktické lékárenství. 2022;18(4):219-223. doi: 10.36290/lek.2022.046.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Reisine T, Pasternak G. Opioid analgesis and antagonists. In: Limbird LE,Hardman JG,eds.Goodman and Gilman's The Pharmacologic Basic of Therapeutic, 9th ed. New York: McGraw- Hill; 1996:521-55.
    2. Liu JG. Anand KJ. Proteni kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev. 2001;381(1-2):1-19. Go to original source... Go to PubMed...
    3. Mao J. NMDA and opiod receptors: their interactions in antinociception, tolerance and neuroplasticity.Brain Res Rev. 1999;30(3):289-304. Go to original source... Go to PubMed...
    4. Davis MP, Quirley C. Methadone. In Davis MP, Glare P, Quirley C, Hardy JR. Opioids in cancer pain. Sec. Edition. Oxford University Press. 2009:211-244. Go to original source...
    5. Caraceni A, Hanks G, Kaasa S. Use of opioid analgesics in the treatment of cancer pain : evidence -based recommendations from the EAPC. Lancet Onkol. 2012;13:58-68. Go to original source... Go to PubMed...
    6. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid­‑induced hyperalgesia. Pain Physician. 2011 Mar­‑Apr;14(2):145-61. Go to original source... Go to PubMed...
    7. Courtemanche F, Dao D, Gagné F, Tremblay L, Néron A. Methadone as a coanalgesic for palliative care cancer patients. J Palliat Med. 2016;19:972-978. Go to original source... Go to PubMed...
    8. Fürst P, Lundström S, Klepstad P, Strang P. The use of low­‑dose methadone as add­‑on to regular opioid therapy in cancer­‑related pain at end of life: a national swedish in specialized palliative care. J palliat Med. 2020;23(2):226-323. Go to original source... Go to PubMed...
    9. McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J. Safe and appropriate use of methadon in hospice and palliative care: expert consencus white paper. J Pain Symptom Manag. 2019;57(3):635-645. Go to original source... Go to PubMed...
    10. SPC Methadon Alkaloid, online [cit. 09-10-2022].
    11. Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep. 1979;63:457-459. Go to PubMed...
    12. Sláma O. Methadon v léčbě nádorové bolesti. Bolest. 2020;2:52-56.
    13. Eap CB, Buclin T, Baumann P. Interindividual variability of clinical pharmakokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmakokinet. 2002;41(14):1153-93. Go to original source... Go to PubMed...
    14. Kristensen K, Blemmer T, Angelo HR, Christrup LL, Drenck NE, Rasmussen SN, et al. Stereoselektive pharmacokinetics of methadone in chronic pain patients. Ther Drug Monit. 1996;18(3):221-7. Go to original source... Go to PubMed...
    15. de Vos JW, Geerlings PJ, van den Brink W, Ufkes JG, van Wilgenburg H. Pharmakokinetcs of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol. 1995;48(5):361-6. Go to original source... Go to PubMed...
    16. Blinick G, Inturrisi CE, Jerez E, Wallach RC. Methadone assays in pregnant women and progeny. Am J Obstet Gynecol. 1975 Mar 1;121(5):617-21. Go to original source... Go to PubMed...
    17. Blinick G, Inturrisi CE, Jerez E, Wallach RC. Amniotic fluid methadone in women maitained on methadone. Mt Sinai J Med. 1974;41(2):254-259.
    18. Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13-24. Go to original source...
    19. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom manage. 2004;25(5):497-504. Go to original source... Go to PubMed...
    20. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002;18(4 Suppl.)3-13. Go to original source... Go to PubMed...
    21. Zünkler BJ, Wos­‑Maganga M. Comparison of the effects of methadone and heroin on human ether­‑à-go­‑go­‑related gene channels. Cardiovasc Toxicol. 2010;10:161-165. Go to original source... Go to PubMed...
    22. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very­‑high­‑dose methadone. Ann Intern Med. 2002 Sep 17;137(6):501-4. Go to original source... Go to PubMed...
    23. Ehret GB, Voide C, Gex­‑Fabry M, et al. Drug­‑Induced Long QT Syndrome in Injection Drug Users Receiving Methadone: High Frequency in Hospitalized Patients and Risk Factors. Arch Intern Med. 2006;166(12):1280-1287. Go to original source... Go to PubMed...
    24. Baumann P. Pharmacokinetic­‑pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet. 1996 Dec;31(6):444-69. Go to original source... Go to PubMed...
    25. Duarte FCN., Ferraro L, Ferreira A, Sakata RK. A Randomized Controlled Trial Evaluating the Analgesic Effect of the Combination of Methadone With Morphine for Cancer Related Pain. Clin. J. Pain. 2021;37:664-668. Go to original source... Go to PubMed...
    26. Palat G, Chary S. Practical guide for using methadone in pain and palliative care practice. Indian J Palliat Care. 2018;2:21-9. Go to original source... Go to PubMed...
    27. Mercadante S, Villari P, Ferrera P., Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: Preliminary data. Support Care Cancer. 2004;12:762-766. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.